Adendra Therapeutics Funding: $53M Raised, Series A (2021)
Adendra Therapeutics is based in Potters Bar, United Kingdom. It has raised $53M in total funding. Latest round: Series A. Backed by Apple Tree Partners.
Adendra Therapeutics funding overview
Adendra Therapeutics is based in Potters Bar, United Kingdom. Adendra Therapeutics has raised $53M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in December 2021. The round record for Adendra Therapeutics runs through 2021; nothing later has been disclosed. Investors on record include Apple Tree Partners.
Adendra Therapeutics at a glance
Total raised
$53M
Latest round
Series A
Latest round date
December 2021
Headquarters
Potters Bar, United Kingdom
Notable investors
Apple Tree Partners
Frequently asked about Adendra Therapeutics funding
How much has Adendra Therapeutics raised?
Adendra Therapeutics has raised $53M in total disclosed funding across the rounds on record.
Who has invested in Adendra Therapeutics?
Apple Tree Partners are named among the investors backing Adendra Therapeutics.
What was the latest Adendra Therapeutics funding round?
The most recent disclosed round is a Series A, announced in December 2021.
Where is Adendra Therapeutics based?
Adendra Therapeutics is based in Potters Bar, United Kingdom.
When did Adendra Therapeutics last raise?
The last disclosed Adendra Therapeutics round closed in December 2021 at Series A.
Adendra Therapeutics totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Potters Bar below to benchmark round size and investor mix.
